Showing results (1781-1790 of 4,181) with videos related to

Sort By:
Pageof 419
Ophthalmology|April 13, 2010
Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery)David H Abramson, Ira J Dunkel, Scott E Brodie, et al.
Medicina (Kaunas, Lithuania)|April 12, 2006
Monthly number of newborns and environmental physical activityElyahu Stoupel, Ramune Kalediene, Jadvyga Petrauskiene, et al.
Respiratory Medicine|May 8, 2007
Associations between reduced diffusing capacity and airflow obstruction in community-based subjectsMelanie C Matheson, Joan Raven, David P Johns, et al.
Applied and Environmental Microbiology|October 1, 1996
Natural contamination of Manitoba barley by 3,15-diacetyldeoxynivalenol and its detection by immunochromatographyE Usleber, D Abramson, R Gessler, et al.
Substance Use & Misuse|February 5, 2026
Intersectional Oppression-Based Stress, School Safety, and Substance Use Among Sexual and Gender Minority Adolescents Who Are Black, Indigenous, and People of ColorJessica R Abramson, Ashwathi Arumugam, Hannah G Vanlandingham, et al.
American Journal of Ophthalmology Case Reports|July 9, 2020
Progressive choroidal thinning (leptochoroid) and fundus depigmentation associated with checkpoint inhibitorsJulia Canestraro, Korey A Jaben, Jedd D Wolchok, et al.
American Journal of Ophthalmology Case Reports|April 25, 2022
Combination intravitreous melphalan and bevacizumb for cutaneous metastatic melanoma to the vitreous and retinaJasmine H Francis, Julia Canestraro, David H Abramson, et al.
Pediatrics|April 30, 2023
The APPD Longitudinal Educational Assessment Research Network's First DecadeAlan Schwartz, Beth King, Richard Mink, et al.
American Journal of Ophthalmology Case Reports|March 6, 2024
Clearance of plasma cell free DNA in metastatic uveal melanoma with radiographic response to immune checkpoint inhibitorsJasmine H Francis, Christopher A Barker, Julia Canestraro, et al.
Critical Reviews in Oncology/Hematology|September 7, 2024
Management of peripheral neuropathy associated with brentuximab vedotin in the frontline treatment of classical Hodgkin lymphomaJeremy S Abramson, Robert Stuver, Alex Herrera, et al.
Pageof 419